PubMed Health⌕ Search

SEARCH · PubMed Health

Results for “ERYTHROPOIESIS”

Explore indexed PubMed citations for clinical trials, systematic reviews and public health research. Read source abstracts and follow each citation to its original PubMed record.

Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.

At least 595 records · Page 33Linked to original sources

Effects of the hormone erythropoietin in milk on erythropoiesis in neonatal rats.

Erythropoiesis was stimulated in 2- to 5-day-old normal neonatal rats nursed by phlebotomized mothers, and in 12-day-old hypertransfused neonatal suckled for 4 days by a twice-bled mother. Erythropoietic stimulation was evidenced as increases in hemoglobin levels and numbers of peripheral reticulocytes in the 2- to 5-day-olds, and by a higher 48-hour RBC-59Fe incorporation in the hypertransfused than in control 12-day-olds. The reticulocyte maturation curve was shifted to the left in 14-day-old transfused rats suckled by an anemic mother, in 14-day-old normal rats suckled by an anemic mother, and in 12-day-old transfused neonates fed cow milk to which erythropoietin (Ep) had been added. The oral administration of cow milk containing Ep to 10-day-old normal neonates induced a reticulocytosis. One-day-old rats suckled by mothers bled 72 h prior to delivery exhibited significant amounts of Ep in their plasma as compared to nondetectable levels in 1-day-old control rats of normal mothers. Decreases in relative percentages of nucleated erythrocytes were noted in spleens of hypertransfused 12-day-old neonates nursed by anemic mothers, in spleens of hypertransfused 12-day-old injected with Ep, and in spleens of 14-day-old normal rats suckled by an anemic mother. Nucleated erythrocyte numbers were reduced in both spleen and marrow of 12-day-old anemic neonates. The data suggest that: Ep is transmitted to neonatal rats via maternal milk, and in the process of gastrointestinal tract absorption, escapes inactivation, thereby stimulating erythropoiesis in these animals; Ep acts on already differentiated erythroid cells by influencing their rate of maturation.

Anemia↗

[Status of erythrocytes and erythropoiesis in alcoholics].

To identify changes in the status of red blood and erythropoiesis in alcoholism, the authors examined three groups of patients aged 18 to 60 years: (1) 146 patients with stage II alcoholism; (2) 97 patients with acute alcoholic hallucinosis; and (3) 76 patients with delirium tremens. The examination revealed a considerable tension of erythropoiesis and erythrodieresis, this being a compensatory response to prolonged and severe hypoxia. At the beginnings of the disease the amount of erythrocytes and total hemoglobin tended to increase, then with the development of psychoses it dramatically decreased resulting in anemia. With disease progression the mean volume of erythrocytes tended to increase consistently reaching the highest values in delirium. This may serve as one of the diagnostic markers of alcoholism to be used in combination with other laboratory tests and clinical findings. The identified decrease in the insulin depositing function of erythrocytes may also indicate that the pancreas has also been involved in the pathological process.

Adolescent↗

Separation of an inhibitor of erythropoiesis in "middle molecules" from hemodialysate from patients with chronic renal failure.

A "middle molecule" inhibitor of erythropoiesis in patients with chronic renal failure was separated from a large amount of hemodialysate. Hemodialysate was passed through Amberlite XAD-4 resin, Sephadex G-50 gel, and DEAE-Sephadex A-25, followed by reversed-phase liquid chromatography. The erythroid colony assay (CFU-E) was used to detect the inhibitory effect of the sample solution. Certain fractions from the DEAE-Sephadex A-25 column showed a dose-related inhibition of CFU-E formation as great as that of standard spermine. The inhibitory effect of these fractions decreased to the control value after proteolytic digestion. The inhibitor was eluted from the liquid-chromatographic column by a solvent gradient containing 390 to 425 mL of methanol per liter. These results suggest there is an inhibitor of CFU-E with a relative molecular mass of 1000 to 10 000 and an active site composed of peptide. This technique may prove useful for separation of the inhibitor of erythropoiesis in uremic body fluid.

Animals↗

Suppression of normal human erythropoiesis by human recombinant DNA-produced alpha-2-interferon in vitro.

Interferons (IFN) have been shown to suppress the proliferation of human erythroid progenitors (BFU-E, CFU-E) in vitro. We have previously demonstrated that the inhibition of erythroid colony formation by gamma-IFN in vitro is mediated, in part, through the activation of monocytes and T-lymphocytes. In order to examine the mechanism(s) underlying the inhibitory action of one type of recombinant alpha-IFN (alpha-2-IFN) on erythropoiesis, the effect of different doses (80-10,000 U) of alpha-2-IFN on erythroid colony formation by normal human bone marrow cells in the presence or absence of monocytes and/or T cells was studied. The addition of alpha-2-IFN to whole marrow caused the suppression of BFU-E (10%-68%) and CFU-E (5%-75%) in a dose-dependent fashion. This inhibition occurred with the direct addition of alpha-2-IFN to culture plates but not with brief preincubation of marrow cells with alpha-2-IFN followed by washing of the cells. By contrast, brief exposure of marrow cells to gamma-IFN resulted in significant suppression of erythroid colony formation. The inhibitory action of alpha-2-IFN was not influenced by erythropoietin. Removal of monocytes and/or T cells prior to the addition of alpha-2-IFN failed to significantly reduce the suppressive effects of this molecule (BFU-E: 21%-66%; CFU-E: 20%-83%). Coculture of purified monocytes or T-lymphocytes preexposed to alpha-2-IFN with autologous bone marrow cells did not cause suppression of erythropoiesis; monocytes or T cells similarly treated with gamma-IFN, however, inhibited autologous BFU-E and CFU-E in vitro. These results demonstrate that, unlike gamma-IFN, the inhibitory effect of alpha-2-IFN on erythroid colony formation in vitro is not mediated to any significant degree through monocytes and T-lymphocytes. The suppressive effect of alpha-2-IFN occurs either directly at the erythroid progenitor(s) level and/or through accessory cell(s) other than monocytes and T cells.

Bone Marrow↗

Erythropoietin and inhibitors of in vitro erythropoiesis in the development of anemia in children with renal disease.

The relative roles of erythropoietin and potential inhibitors of erythropoiesis in the development of anemia in children with renal disease have been studied. Thirty-five children with renal disease of varied origins and severity were compared with 30 children with anemia of similar severity and with normal renal function. Serum erythropoietin was measured by radioimmunoassay; erythroid (CFU-E) and granulocytic (CFU-GM) progenitor cell growth were assessed in fetal mouse liver cell and normal human bone marrow cell cultures, respectively. The degree of serum inhibition of in vitro CFU-E growth in children with renal disease correlated with both creatinine clearance (r = 0.59, P less than 0.001) and hematocrit level (r = 0.55, P less than 0.005). Serum from children with renal disease inhibited in vitro CFU-E growth in a dose-related manner. Normal serum did not inhibit CFU-E growth in culture. The mean serum erythropoietin concentration was significantly (P less than 0.025) higher in children with anemia of renal disease (32.4 +/- 2.4 mU/ml) in comparison with serum values in normal children (19.6 +/- 1.5 mU/ml), but serum erythropoietin levels did not correlate with hematocrit level, creatinine clearance, or serum inhibition of in vitro erythropoiesis. In contrast, children with anemia and normal renal function showed a significant (P less than 0.001) linear increase in serum erythropoietin concentration (range 28.7 to 327 mU/ml), increased reticulocyte count, and stimulation of CFU-E formation with decreasing hematocrit levels. Coincubation of human urinary erythropoietin in the presence of serum from patients with uremia revealed markedly less immunoreactivity in the radioimmunoassay and less biologic activity in the fetal mouse liver CFU-E assay for erythropoietin than when erythropoietin was incubated with normal human serum, suggesting some alteration of erythropoietin in the presence of uremic serum, which reduced both the immunologic and biologic activity of erythropoietin. Normal and uremic sera inhibited CFU-GM growth to the same degree in comparison with controls. In conclusion, relative erythropoietin deficiency, direct alteration in the biologic activity of erythropoietin by uremic toxins, and serum inhibition of erythroid progenitor cells in the bone marrow are probably important factors in the pathogenesis of anemia in children with renal disease.

Acute Kidney Injury↗

Regulation of erythropoiesis in long-term hamster marrow cultures: role of bone marrow-adherent cells.

The initial establishment of hamster long-term bone marrow (LTBM) cultures requires formation of an adherent stromal layer, but continued long-term proliferation of these cultures is best accomplished by removal of the suspension cells from the adherent layer and subsequent incubation in liquid suspension culture. Continued maintenance of bone marrow cells in the presence of the adherent layer for more than four to six weeks leads to a decline and eventual disappearance of erythroid and multipotent colony-forming cells. Addition of erythropoietin to LTBM suspension cultures produces mature, hemoglobinized erythrocytes. Incubation of the same cells plus erythropoietin in the presence of autologous parental adherent layers markedly inhibits both terminal erythroid differentiation and the number of detectable erythroid burst-forming units (BFU-Es). This erythroid inhibition occurs primarily within the first 24 hours with little or no effect on CFU-GEMMs or granulocyte-macrophage colony-forming units (GM-CFUs). However, continued incubation for seven days produces a reduction in all parameters. Removal of suspension cells from the adherent layer and restimulation with erythropoietin allows regeneration of erythropoiesis. Pretreatment of suspension cells with erythropoietin for 96 hours before exposure to the adherent culture only slightly inhibits erythropoiesis, suggesting that more mature erythroid progenitors are unaffected. Conditioned medium from the marrow adherent layer (ALCM) produces similar erythroid inhibitory effects in LTBM cultures with as little as two hours of incubation. The inhibition is actively produced by the adherent cells, since cycloheximide abolishes its production, while indomethacin has no apparent effect. Adherent marrow stromal cells may regulate hemopoiesis through negative as well as positive humoral signals, and they are particularly effective in erythroid regulation.

Alprostadil↗

Inhibition of erythropoiesis by plasma component(s) from sheep, goats, and rabbits.

Plasma from hypertransfused and normal sheep and experimentally induced anemic and normal goats was fractionated by ultrafiltration. Fractions obtained were assayed for erythropoiesis stimulatory factor (ESF) or erythropoiesis inhibitory factor (EIF) activity (or both) in the posthypoxic polycythemic mouse assay. The most potent sheep plasma-inhibitor fraction was found in the retentate on a membrane with a cutoff at mol wt 50,000. The most potent EIF fraction from anemic goats passed into the ultrafiltrate, but the comparable EIF from normal goats remained in the retentate on a membrane with a cutoff at mol wt 500. The yield of the most potent EIF fraction was higher from anemic goats than was the yield from normal goats. During thin-layer chromatography, EIF extracted from goat plasma fractions had the same mobility as did prostaglandin F2 alpha. Cohn rabbit plasma fraction IV-4 had an inhibitory factor, and a benzene extract of the fraction contained a component that had the same mobility as did prostaglandin F2 alpha. Cohn rabbit plasma fraction V contained a component that potentiated an erythropoietin-generating factor.

Animals↗

THe dynamics of erythropoiesis inhibition in posttransfusion polycythaemia in the rat.

The dynamics of erythropoiesis inhibition as the consequence of polycythaemia induced in rats by four to six transfusions of homologous erythrocytes was studied in detail. It was found, that, in rats with polycythaemia elicited by two transfusions of erythrocytes, erythropoiesis inhibition occurs 67h after the first transfusion and it is most pronounced in the period between 115-187 h. The hemopoietic system is not completely free from the inhibitory influence of polycythaemia up to 283 h after the first transfusion. Maintenance of a state of polycythaemia for 17 days by repeated transfusions strongly and durably inhibits the haemopoietic system. The red blood cell system remained for this whole period under the inhibitory effect.

Animals↗

An electron microscopic study of hepatic erythropoiesis in adult mice with Friend virus disease.

A polycythemia-inducing strain of Friend virus was injected into adult mice. Animals were sacrificed on days 2, 5, 9, 11, and 14, and specimens of liver were fixed and embedded for light and electron microscopy. From some mice, samples of bone marrow and spleen were also processed for microscopy. Hepatic erythropoiesis was established as early as 2 to 5 days after inoculation. Often, red cell maturation occurred in typical islands. These included a central macrophage which in many instances appeared to be a Kupffer cell. The number and size of red cell foci increased through day 14. Extensive ineffective erythropoiesis involving erythroblast death occurred within these foci. This premature cell death may be related to large inclusions, thought to be autophagosomes, in the cytoplasm of erythroblasts. A few undifferentiated cells, presumed to be the reticulum cells of Friend virus disease, were observed in the liver at 9 to 14 days after infection. The morphology of these cells resembled that of primitive hemopoietic elements. These studies indicate that the liver, along with the spleen, contributes to the polycythemia in the early phase of Friend virus disease.

Animals↗

Erythropoietin and the regulation of erythropoiesis.

Recent advances in experimental hematology have provided new insight into the physiology of erythropoiesis. Techniques are now available for cloning in vitro the various hematopoietic progenitor cells of both animals and man. Erythropoietin has been purified and a radioimmunoassay for the hormone has been described. In this paper, we discuss the physiology of erythropoietin and erythropoiesis with special emphasis on data obtained through the employment of new technology.

Anemia↗

[Measurement of the intensity of erythropoiesis based on the RNA content of erythrocytes].

The relationship between RNA content in erythrocytes and the erythropoiesis rate was studied at varying exposures as a result of which a simple method for erythropoietic activity testing was proposed. It consists in the measurement of ribonucleic acid content in erythrocytes of mice with a decreased erythropoiesis after administration of the test sample. Erythropoietic activity is determined from the magnitude found. The method suggested is marked by simplicity and higher sensitivity and thus may be applied in clinical medicine and research.

Animals↗

Chromatin conjugate protein A24 is cleaved and ubiquitin is lost during chicken erythropoiesis.

The content of protein A24, an adduct of histone 2A and ubiquitin, was studied during chicken erythropoiesis. The amount of protein A24 was negligible in transcriptionally inactive mature chicken erythrocyte nuclei and 6-fold higher in the transcriptionally active nuclei of erythroid cells from phenylhydrazine-treated chickens. The decreased amount of protein A24 in the mature cells was offset by the relatively increased amount of histone 2A. A loss of free ubiquitin was also noted. In contrast, the amounts of high mobility group proteins 1,2, and E were essentially constant. Inasmuch as cleavage of the ubiquitin---histone 2A bond of protein A24 and loss of ubiquitin accompanied transcriptional shutdown during erythropoiesis, the presence of protein A24 and ubiquitin in premature polychromatic erythrocytes may reflect the presence of potentially active and transcribing chromatin structures.

Animals↗

High levels of the circulating form of parathyroid hormone do not inhibit in vitro erythropoiesis.

Either primary or secondary hyperparathyroidism may be associated with anemia. The pathogenesis of this anemia remains obscure, but parathyroid hormone may directly suppress erythropoiesis or anemia may result from myelofibrosis. Previously reported in vitro studies of a direct inhibitory effect of PTH on erythroid progenitor growth were carried out with crude hormone preparations and appeared nonspecific. We have studied simultaneously the in vitro effects of pure (greater than 6000 U/mg) and crude (130 U/mg) preparations of PTH on murine and human hematopoietic progenitor growth. Increasing concentrations (2.5 to 20 U/ml) of crude PTH produced a dose-dependent inhibition of early erythroid (BFU-E) and granulocyte/macrophage progenitor (CFU-GM) growth in human and mouse marrow cell cultures. However, the biologically active N-terminal fragment containing amino acids 1-34 and the pure intact molecule of 84 amino acids failed to significantly inhibit hematopoietic colony growth. These observations demonstrate that in vitro inhibitory effects described with parathyroid gland extracts are not specific for erythropoiesis and may not be related to the circulating form of PTH.

Animals↗

Role of cell--cell interaction in normal and abnormal erythropoiesis.

A number of studies have demonstrated that certain immunocompetent cells play a role in the regulation of normal erythropoiesis. These regulatory cells (monocytes--macrophages, lymphocytes) modulate almost every phase of the erythropoietic process, and along with erythropoietin represent the major controlling force in erythropoiesis. Evidence indicate that pathological alterations of these cell-mediated activities can lead to clinical disturbances of red cell production such as is seen in patients with Diamond-Blackfan syndrome and aplastic anemia.

Anemia, Aplastic↗

Regulation of erythropoiesis.

The regulation of erythropoiesis is an important factor in maintaining normal blood viscosity. In this short summary the three erythroid compartments in the bone marrow are described: the stem cells, the committed cells and the morphologically recognisable cells. The stimulating factors burst forming activity (BFA) and erythropoietin (Ep) act on the committed cells. The production of Ep is regulated through tissue oxygenation while BFA seems to be unrelated to this. Under normal conditions erythropoiesis is a well regulated system, while under pathological conditions it may escape control and thus give rise to very high haematocrits and increased blood viscosity.

Blood Viscosity↗

Polyamine induced suppression of erythropoiesis in uremia.

The effect of the polyamine spermine previously shown to suppress erythropoiesis in vitro was investigated in a long term animal experiment. Continuous application of spermine by intraperitoneally implanted microperfusion pumps caused a mild hypoproliferative microcytic anemia in normal rats. Furthermore, in 12 patients with advanced renal insufficiency spermine was shown to be markedly elevated. This, together with the results obtained in animal experiments, suggests that hypersperminemia is the reason for the impaired erythropoiesis in anemic uremic patients.

Anemia↗

The 2'-5' adenylate (2-5A) system in erythropoiesis.

The trimer and tetramer core forms of 2'-5' Adenylate (2-5A) were tested in vitro for their effect on mouse liver CFU-E. Both forms of 2-5A core partially inhibited the CFU-E response to erythropoietin when given as a single dose at time 0 hours. Approximately 25% fewer colonies were seen after 2-days growth following exposure of the CFU-E to 0.1 mM 2-5A core. A 0.01 mM concentration of exogenous 2-5A core was not inhibitory. Endogenous 2-5A synthetase activity was assayed in spleen cell lysates from mice made anemic by several injections of phenylhydrazine. This method of treatment stimulated erythropoiesis, and this was directly correlated with an increase in the rate of enzyme activity measured by lysate conversion of 14C-ATP to 2-5A (our in press data suggests that the same may occur with hypoxic stimulation). This suggested to us that endogenous 2-5A synthetase and its 2-5A, a known inhibitor of DNA synthesis and protein synthesis, may help to regulate some of the late events in erythropoiesis.

2',5'-Oligoadenylate Synthetase↗